Financials

News Discussions Technicals Seasonals

476060 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ONCONIC THERAPEUTICS INC. operating, investing, and financing activities

476060 free cash flow for Q1 25 is 1.23 B KRW. For 2024, 476060 free cash flow was -7.98 B KRW and operating cash flow was -7.84 B KRW.

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—